Search
User Avatar Login
The Defender
  • Explore The Defender
  • Categories
    • CHD.TV
  • Explore CHD.TV
  • Archive
    • Resources
  • Explore Our Resources
  • CHD Bookstore
  • CHD Films
  • eBooks
    • Advocacy
  • Explore Advocacy
  • Community
  • Advocacy Help
    • Science
  • Explore the Science Section
  • Science Library
  • Vaccines
  • Electromagnetic Radiation
    • Legal Justice
  • Explore Litigation
  • Learn The Law
    • About Us
  • About Children’s Health Defense
  • More from CHD
    • The Wuhan Cover-Up Book › Citations

    Chapter 21

    This is a listing of all citations in this chapter.

    1

    “Gain-of-Function Deliberative Process Written Public Comments, Oct. 19, 2014-Jun. 8, 2016, (Ralph Baric, PhD & Mark Denison, MD),” NSABB, Nov. 12, 2014, 25-29.

    2

    Ibid.

    3

    Ibid.

    4

    Ibid.

    5

    “NIH/NIAID Funding: Ralph S. Baric, 2014,” NIH RePORTER.

    6

    Jocelyn Kaiser, “Moratorium on Risky Virology Studies Leaves Work at 14 Institutions in Limbo,” Science, Nov. 17, 2014.

    7

    Cherry Mason and Vivien Dugan, PhD, to Sherrie Settle, Dr. Ralph Baric, Mary Kirker and Dr. Irene Glowinski, Oct. 21, 2014, 64-65.

    8

    Nell Greenfieldboyce, “Scientists Fight for Superbug Research as U.S. Pauses Funding,” NPR, Oct. 23, 2014.

    9

    “NIH/NIAID Funding: Systems Immunogenetics of Biodefense Pathogens in the Collaborative Cross,” NIH RePORTER, 2012-2016.

    10

    “NIH/NIAID Funding: Characterization of Novel Genes Encoded ty RNA and DNA Viruses,” NIH RePORTER, 2013-2017.

    11

    Judicial Watch, “Judicial Watch: New Documents Show Wuhan Lab Asked NIH Official for Information on Disinfectants; Nine Fauci Agency Grants for EcoHealth Bat Coronavirus Research,” press release, Jul. 8, 2021.

    12

    “NIH/NIAID Funding: Ralph Baric, 2014,” NIH RePORTER.

    13

    Vineet Menachery, Zhengli-Li Shi, Ralph Baric et al., “A SARS-like Cluster of Circulating Bat Coronaviruses Shows Potential for Human Emergence,” Nature Medicine 21, no. 12 (2015): 1508-1513, doi: 10.1038/nm.3985.

    14

    Shi Zhengli, Peter Daszak et al., “Isolation and Characterization of a Bat SARS-like Coronavirus That Uses the ACE2 Receptor,” Nature 503, no. 7477 (2013): 535-538, doi: 10.1038/nature12711.

    15

    David Stanway, “Explainer: China’s Mojiang Mine and Its Role in the Origins of COVID-19,” Reuters, Jun. 9, 2021.

    16

    Declan Butler, “Engineered Bat Virus Stirs Debate over Risky Research,” Nature News (2015), doi: 10.1038/nature.2015.18787.

    17

    Vineet D. Menachery, Boyd L. Yount, Jr., Ralph S. Baric et al., “SARS-like WIV1-CoV Poised for Human Emergence,” PNAS 113, no. 11 (2016): 3048-3053, doi: 10.1073/pnas.1517719113.

    18

    Vineet Menachery, Zhengli-Li Shi, Ralph Baric et al., “A SARS-like Cluster of Circulating Bat Coronaviruses Shows Potential for Human Emergence,” Nature Medicine 21, no. 12 (2015): 1508-1513, doi: 10.1038/nm.3985.

    19

    Ibid.

    20

    Nicholson Baker, “The Lab-Leak Hypothesis: For Decades, Scientists Have Been Hot-Wiring Viruses in Hopes of Preventing a Pandemic, Not Causing One. But What If . . .?” Intelligencer, Jan. 4, 2021.

    21

    Vineet Menachery, Zhengli-Li Shi, Ralph Baric et al., “A SARS-like Cluster of Circulating Bat Coronaviruses Shows Potential for Human Emergence,” Nature Medicine 21, no. 12 (2015): 1508-1513, doi: 10.1038/nm.3985.

    22

    “US. Government Gain-of-Function Deliberative Process and Research Funding Pause on Selected Gain-of-Function Research Involving Influenza, MERS, and SARS Viruses,” HHS Office of the Assistant Secretary for Preparedness and Response, Oct. 17, 2014.

    23

    Jocelyn Kaiser, “Moratorium on Risky Virology Studies Leaves Work at 14 Institutions in Limbo,” Science, Nov. 17, 2014. *See “copies of the 18 letters.”

    24

    Jocelyn Kaiser, “Moratorium on Risky Experiments Lifted for MERS Mouse Studies,” Science, Dec. 18, 2014.

    25

    David Willman and Madison Muller, “A Science in the Shadows,” Washington Post, Aug. 26, 2021.

    26

    Ibid.

    27

    “Gain-of-Function Deliberative Process Written Public Comments, Oct. 19, 2014-Jun. 8, 2016, (Ralph Baric, PhD & Mark Denison, MD),” NSABB, Nov. 12, 2014, 25-29.

    28

    “NIH/NIAID Funding: Mechanisms of MERS-CoV Entry, Cross-Species Transmission and Pathogenesis, 2015-2020” NIH RePORTER.

    29

    “Curriculum Vitae, Ralph S. Baric,” UNC, Nov. 2021.

    30

    “NIH/NIAID Funding: Ralph S. Baric 1986-2023,” NIH RePORTER accessed May 29, 2023.